VIZARSIN 100 mg, tablets orodispersible 24 tablets
Active ingredients: Sildenafil
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet24 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIZARSIN 100 mg, comprimés orodispersibles
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- 24 plaquette(s) thermoformée(s) polyamide aluminium PVC polytéréphtalate (PET) de 1 comprimé(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61645318CIP73033898CIP133400930338988Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SILDÉNAFILcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.